Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
Deep Learning Model Accurately Predicts RNA-Targeting CRISPR Activity

Deep Learning Model Accurately Predicts RNA-Targeting CRISPR Activity

Camena Bioscience Closes $10m Series A Financing as Demand for DNA Synthesis Technology Increases

Camena Bioscience Closes $10m Series A Financing as Demand for DNA Synthesis Technology Increases

Theta Supercomputer Used To Find Essential Factors That Control Structural Change of HIV Protease

Theta Supercomputer Used To Find Essential Factors That Control Structural Change of HIV Protease

Metrion Biosciences Appoints Dr Steve Jenkinson as VP, Drug Discovery and Safety Assessment to Strengthen US Operations

Metrion Biosciences Appoints Dr Steve Jenkinson as VP, Drug Discovery and Safety Assessment to Strengthen US Operations

Research Uncovers the Biology Underpinning a Rare Genetic Mutation Linked to Painlessness

Research Uncovers the Biology Underpinning a Rare Genetic Mutation Linked to Painlessness

An In-Depth Analysis of the Human Genome Using the New “Pangenome”

An In-Depth Analysis of the Human Genome Using the New “Pangenome”

New Method for Analyzing Protein Crystals Could Open Up Applications for Drug Discovery

New Method for Analyzing Protein Crystals Could Open Up Applications for Drug Discovery

Using Mass-Spectrometry-Based Cancer Proteomics Datasets to Discover Potential Therapeutic Targets

Using Mass-Spectrometry-Based Cancer Proteomics Datasets to Discover Potential Therapeutic Targets

Discovering Novel Senolytic Compounds with the Power of Artificial Intelligence

Discovering Novel Senolytic Compounds with the Power of Artificial Intelligence

Analyzing the Complex Sequence of Events Involved in Beta-Arrestin Interactions

Analyzing the Complex Sequence of Events Involved in Beta-Arrestin Interactions

Reducing Intracellular Ice Formation in Advanced Cell Models

Reducing Intracellular Ice Formation in Advanced Cell Models

3D Genome Mapping may Lead to Targeted Therapeutic Options for Ependymoma

3D Genome Mapping may Lead to Targeted Therapeutic Options for Ependymoma

Mirror-Image Versions of a Small Molecule Pave New Way for Cancer Drug Discovery

Mirror-Image Versions of a Small Molecule Pave New Way for Cancer Drug Discovery

High-Throughput Assay to Analyze the Effects of CAR-T Cells Using Image Cytometry

High-Throughput Assay to Analyze the Effects of CAR-T Cells Using Image Cytometry

Increased Fucose Digestion by Gut Bacteria Linked to Lower Immune Responses to COVID-19 Vaccine

Increased Fucose Digestion by Gut Bacteria Linked to Lower Immune Responses to COVID-19 Vaccine

Entry of Aging-Associated Enzymes into Human Genetic Material

Entry of Aging-Associated Enzymes into Human Genetic Material

Study provides a feasible tool to evaluate vesicular endocytosis of NPC1L1-cargos and cholesterol absorption

Study provides a feasible tool to evaluate vesicular endocytosis of NPC1L1-cargos and cholesterol absorption

New inhibitor molecule disrupts the infection mechanism of SARS-CoV-2 coronavirus

New inhibitor molecule disrupts the infection mechanism of SARS-CoV-2 coronavirus

How can the adoption of AI technology accelerate drug discovery?

How can the adoption of AI technology accelerate drug discovery?

Uncovering the role of the third intracellular loop in the GPCR’s signaling mechanism

Uncovering the role of the third intracellular loop in the GPCR’s signaling mechanism

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.